GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹3,328 Cr | ₹1,609 Cr | ₹3,877 Cr | ₹3,593 Cr | ₹3,159 Cr |
What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹3,328 Cr |
| Mar2024 | ₹1,609 Cr |
| Mar2023 | ₹3,877 Cr |
| Mar2022 | ₹3,593 Cr |
| Mar2021 | ₹3,159 Cr |
How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,328 Cr | 106.80 | |
| Mar2024 | ₹1,609 Cr | -58.49 | |
| Mar2023 | ₹3,877 Cr | 7.92 | |
| Mar2022 | ₹3,593 Cr | 13.75 | |
| Mar2021 | ₹3,159 Cr | - | |
Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,793.1 Cr | 5% | 1% | 7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 5% |
1% |
7.8% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses